Stratview Research has launched a new report, titled Glucose Monitoring System Market, By Type (Sensors, Transmitters & Receivers, Integrated Insulin Pumps), End-User (Hospitals, Clinics, Home Healthcare), and Region.
Covid-19 Impact Analysis:
Covid-19 has highly impacted the market dynamics, competition, and supply chain of almost all industries. The revenues have gone down in 2020 and are expected to resume an uptrend gradually from 2021 and continue to grow further. The report covers all the segments that were affected by the pandemic.
According to the report, The Glucose Monitoring System market is projected to grow from USD 1.9 billion in 2020 to USD 2.7 billion by 2026 at a CAGR of around 6.1% during the forecast period.
Market Segments’ Analysis
By end-user, the glucose monitoring system market has been bifurcated into hospitals, clinics, and home healthcare. Under these, the hospitals’ segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of established healthcare infrastructure, technical expertise, and professional healthcare staff.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth is primarily attributed to expanding geriatric populace and rising incidences of diabetes coupled with the presence of key market players such as Echo Therapeutics Inc. (US) and Insulet Corporation (US). The market growth in the Asia-Pacific region is expected to be driven by the increasing number of people having diabetes due to a sedentary lifestyle in developing countries, particularly China and India.
Key Players
The following are the key players in the Glucose Monitoring System Market.
- Medtronic plc (Ireland)
- Abbott Laboratories (US)
- DexCom, Inc. (US)
- Echo Therapeutics Inc. (US)
- Insulet Corporation (US)
- Johnson & Johnson (US)
- Senseonics Holdings, Inc. (US)
- F. Hoffmann-La Roche AG (Switzerland)
- AgaMatrix Inc. (Germany)
- Glysure Ltd (UK)
- ORSENSE LTD (Israel)
- Ypsomed (Switzerland)
Frequently Asked Questions –
This report provides vital information and valuable insights, enabling the users to identify the strategic growth opportunities in the market. The report aims at answering the following key questions:
- What is the current and future market size of Glucose Monitoring System Market?
- How has the COVID-19 pandemic impacted the market? How fast is it expected to recover?
- What will be the short and long-term effects of the pandemic?
- How are other market factors affecting the market dynamics?
- Which segments offer high-growth opportunities in the long run?
- How fierce is the Glucose Monitoring System Market competition?
- What are the key emerging trends and unmet needs in the present market?
- What are the strategic growth opportunities and key success factors?
Read the full report: here
Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement or any further query related to the report, please send your inquiry to sales@stratviewresearch.com. You may also connect with our market experts at +1-313-307-4176.
About Stratview Research
Stratview Research is a global market research firm that provides high-quality market research reports, market entry strategies, growth strategies, and more. We in-depth market research studies, to help the users obtain grainy level clarity on present business trends and probable future developments. At Stratview Research, the market experts are committed to providing custom solutions best fit for strategy development and implementation to achieve visible growth.